Cassava Sciences Inc

Company Profile

Cassava Sciences Inc had its IPO on 2000-07-14 under the ticker symbol SAVA.

The company operates in the Healthcare sector and Biotechnology industry. Cassava Sciences Inc has a staff strength of 26 employees.

Stock update

Shares of Cassava Sciences Inc opened at $20.67 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $19.14 - $20.8, and closed at $19.36.

This is a -7.32% slip from the previous day's closing price.

A total volume of 928,571 shares were traded at the close of the day’s session.

In the last one week, shares of Cassava Sciences Inc have slipped by -7.98%.

Cassava Sciences Inc's Key Ratios

Cassava Sciences Inc has a market cap of $883.05 million, indicating a price to book ratio of 9.2662 and a price to sales ratio of 0.

In the last 12-months Cassava Sciences Inc’s revenue was $0 with a gross profit of $-68032000 and an EBITDA of $-96100000. The EBITDA ratio measures Cassava Sciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cassava Sciences Inc’s operating margin was 0% while its return on assets stood at -28.72% with a return of equity of -45.28%.

In Q2, Cassava Sciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Cassava Sciences Inc’s PE and PEG Ratio

Forward PE

56.4972

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.2 per share while it has a forward price to earnings multiple of 56.4972 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cassava Sciences Inc’s profitability.

Cassava Sciences Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -23.0543. Its price to sales ratio in the trailing 12-months stood at 0.

Cassava Sciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$197.25 million

Total Liabilities

$17.90 million

Operating Cash Flow

$6000.00

Capital Expenditure

$6000

Dividend Payout Ratio

0%

Cassava Sciences Inc ended 2024 with $197.25 million in total assets and $0 in total liabilities. Its intangible assets were valued at $197.25 million while shareholder equity stood at $179.35 million.

Cassava Sciences Inc ended 2024 with $0 in deferred long-term liabilities, $17.90 million in other current liabilities, 513552000.00 in common stock, $-334199000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $168.44 million and cash and short-term investments were $168.44 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Cassava Sciences Inc’s total current assets stands at $174.53 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $1.33 million compared to accounts payable of $10.34 million and inventory worth $-1328000.00.

In 2024, Cassava Sciences Inc's operating cash flow was $6000.00 while its capital expenditure stood at $6000.

Comparatively, Cassava Sciences Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$19.36

52-Week High

$51.59

52-Week Low

$16.55

Analyst Target Price

$99.5

Cassava Sciences Inc stock is currently trading at $19.36 per share. It touched a 52-week high of $51.59 and a 52-week low of $51.59. Analysts tracking the stock have a 12-month average target price of $99.5.

Its 50-day moving average was $20.29 and 200-day moving average was $25.75 The short ratio stood at 15.12 indicating a short percent outstanding of 0%.

Around 603.5% of the company’s stock are held by insiders while 2897.5% are held by institutions.